Atea Pharmaceuticals, Inc. (AVIR)

NASDAQ: AVIR · Real-Time Price · USD

4.730

+0.180 (3.96%)

At close: May 28, 2026, 4:00 PM EDT

4.860

+0.130 (2.75%)

After-hours: May 28, 2026, 4:49 PM EDT

Atea Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	79.32	95.71	64.7	143.82	188.46	764.38
Short-Term Investments	176.69	206.12	390.03	434.28	458.25	-
Cash & Short-Term Investments	256.01	301.83	454.72	578.11	646.71	764.38
Cash Growth	-39.83%	-33.62%	-21.34%	-10.61%	-15.39%	-10.09%
Other Current Assets	7.19	9.16	7.63	12.35	14.21	8.03
Total Current Assets	263.2	310.99	462.36	590.46	660.92	772.4
Net Property, Plant & Equipment	0.83	1.09	2.12	3.12	4.09	0.18
Other Long-Term Assets	3.05	3.14	0.2	1.4	1.69	0.31
Total Assets	267.08	315.22	464.67	594.97	666.71	772.89
Accounts Payable	9.45	12.95	4.46	4.25	2.55	4.53
Accrued Expenses	23.29	26	13.35	27.36	15.21	52.15
Current Portion of Leases	0.63	0.84	0.8	0.76	0.72	0.2
Total Current Liabilities	33.37	39.78	18.6	32.38	18.48	56.88
Long-Term Leases	-	-	0.84	1.64	2.4	-
Other Long-Term Liabilities	-	-	6.36	5.76	5.26	5.93
Total Long-Term Liabilities	-	-	7.2	7.4	7.66	5.93
Total Liabilities	33.37	39.78	25.8	39.78	26.14	62.82
Common Stock	0.08	0.08	0.08	0.08	0.08	0.08
Additional Paid-in Capital	801.74	797.75	802.77	750.74	701.05	653.96
Accumulated Other Comprehensive Income	-0.1	0.17	0.23	0.21	-0.68	-
Retained Earnings	-	-	-	-195.84	-59.88	56.03
Shareholders' Equity	801.72	798	803.09	555.19	640.57	710.08
Total Liabilities & Equity	835.09	837.79	828.89	594.97	666.71	772.89
Total Debt	0.63	0.84	1.64	2.4	3.12	0.2
Net Cash (Debt)	255.37	300.99	453.08	575.7	643.59	764.18
Net Cash Growth	-15.15%	-33.57%	-21.30%	-10.55%	-15.78%	-10.11%
Net Cash Per Share	3.19	3.69	5.38	6.90	7.73	8.66
Book Value	801.72	798	803.09	555.19	640.57	710.08
Book Value Per Share	10.02	9.79	9.53	6.66	7.69	8.05
Tangible Book Value	801.72	798	803.09	555.19	640.57	710.08
Tangible Book Value Per Share	10.02	9.79	9.53	6.66	7.69	8.05

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q